Login
Toggle navigation
Videos
Categories
Trending
Stefan Poz on Moonfare's Mission and the Impact of ELTIF 2.0
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Dr. Steffen Pauls, CEO and Founder at Moonfare. Former Managing Director at KKR
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
BBK’s Commitment to Sustainable Development and Social Impact in Biscay
00:10:00
Silver One: Revitalizing Historic Silver Mines and Exploring New Opportunities
00:10:00
Enea CEO Jan Häglund explains why his company has been expanding its portfolio of data management tools and capabilities, highlighting Enea's strategic positioning in the market.
00:10:00
Michael Saylor, Chairman & CEO of MicroStrategy, Inc., speaks with Bloomberg's Joe Weisenthal at the Bloomberg Crypto Summit about cryptocurrency strategies.
00:10:00
Invests in early-stage startups that are disrupting the consumer entertainment industry|Yasushi Komori,General Partner,GFR Fund
00:10:00
Why Choose Legacy Financial Strategies? | Michael Lutz, CEO, Legacy Financial Strategies, LLC.
00:10:00
Legacy: Tailored Financial Solutions for Businesses and Executives
00:10:00
Steve Adubato and Mary Gamba discuss with Larry Downes the critical role of continuous learning in personal and professional growth.
00:10:00
PECVD 200™ & FEL 200™: High-Performance Plasma CVD System | Emmanuel Lakios, President and CEO of CVD Equipment Corp
00:10:00
JPMorgan Shines Bright: Colin Stewart Discusses U.S. Bank Earnings and 2024 Investment Landscape
00:10:00
Next Demba Sow from Alsace France pitched Hodi Hodi|Vincent Diallo,Founder & General Partner,Interlace Ventures
00:10:00
Expanding Gold Resource Potential in Côte d'Ivoire: Insights from a Leading West African Project